Institut de Cancérologie Strasbourg

Recent papers from Institut de Cancérologie Strasbourg

1. Outcomes of ibrutinib plus lenalidomide combination in patients with large Bcell lymphoma refractory to or relapsing after CAR-T-cell therapy and who failed or were ineligible for bispecific antibodies: a multicenter real-world REALI-T studyHaematologica · 2026
2. Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trialThe Lancet · 2025
3. Curative-Intent Cryoablation for Bone Metastases: Study Protocol for BOREALIS, a Prospective Multicentre Observational InvestigationCardioVascular and Interventional Radiology · 2026
4. Treatment patterns and outcomes in advanced and metastatic lung cancer in France: Results from the Epidemiological Strategy and medical Economics (ESME) database lung cancer in FranceLung Cancer · 2026
5. Cerebrospinal Fluid Circulating Tumor DNA Profiling in Central Nervous System Metastases from Solid Tumors: A Prospective Multicentre Translational Analysis of the BrainStorm (OncoDistinct-006) StudyThe Journal of Liquid Biopsy · 2026
6. Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic CancerJournal of Clinical Oncology · 2026
7. Combined Anterior Cruciate Ligament Reconstruction and Lateral Extra‐articular Tenodesis With Augmented Continuous Iliotibial Band AutograftArthroscopy Techniques · 2026
8. Prognostic Impact of Concomitant Genomic Alterations in FGFR2 ‐Positive Cholangiocarcinoma Treated With PemigatinibLiver International · 2026
9. The Circulating Cholangiocarcinoma Protein Biomarkers CRP and MASP2 Also Predict Gallbladder Cancer RiskInternational Journal of Cancer · 2026
10. Tyrosine kinase inhibitors in Kosaki/Penttinen syndromes: new reports, follow-up of treated individuals and literature reviewEuropean Journal of Human Genetics · 2026
11. Baseline value and longitudinal kinetics of circulating nucleosomes during neo-adjuvant chemotherapy in newly diagnosed ovarian cancer: Results from a GINECO/GINEGEPS study of the randomized phase II CHIVA trialTranslational Oncology · 2026
12. Surface‐guided analysis of breast shape changes during postoperative radiotherapy by using a functional map frameworkMedical Physics · 2026
13. Prognostic value of [18F]FDG PET/CT and PERCIST criteria in patients with HER2-low metastatic breast cancer treated with trastuzumab deruxtecanEuropean Journal of Nuclear Medicine and Molecular Imaging · 2026
14. Base of tongue volume and dose as predictors of late dysphagia after definitive or adjuvant radiotherapy for oral cavity squamous cell carcinomaPhysics and Imaging in Radiation Oncology · 2026
15. From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastomaJournal of Neuro-Oncology · 2026
16. Survey of the Senologic International Society (SIS) on the Use of Preoperative Breast MRI in Early-Stage Breast Cancer: A Global Perspective on Current PracticeEuropean Journal of Breast Health · 2026
17. High-fat, low-carb diet reduces tumor growth and induces liver metabolism remodeling in a breast cancer mouse modelAJP Cell Physiology · 2026
18. Effectiveness of pegylated liposomal doxorubicin (Caelyx®) monotherapy in patients with metastatic HER2-low breast cancer: a monocentric retrospective studyCancer Treatment and Research Communications · 2026
19. Individualized recurrence risk prediction as a challenge to conventional eligibility criteria in phase III adjuvant immunotherapy trials for renal cell carcinoma.Journal of Clinical Oncology · 2026
20. Final analysis of the TiNivo-2 phase 3 trial: Long-term outcome of tivozanib (Tivo) in patients with metastatic renal cell carcinoma (mRCC).Journal of Clinical Oncology · 2026